Conversation

4:06 pm ET *Immunic Reports That Its IMU-838 Has Demonstrated Preclinical Activity Against SARS-Coronavirus And Explores Plans For A Phase 2 Clinical Trial In Coronavirus Patients(Benzinga)

8:44 PM · Apr 21, 2020Twitter Web App

Likes

This Tweet is unavailable. Learn more

Replying to

$$$$$$$$$$$ Yaya!

Replying to

and

Very nice call ,,,, 🚀

Replying to

and

Replying to

and

Where do you mostly find news on the stock market? Can’t decide which sources I should subscribe to